Multilevel botulinum toxin type a as a treatment for spasticity in children with cerebral palsy: a retrospective study

INTRODUCTION: Cerebral palsy is the most common cause of physical disability in children. Spasticity is a disabling clinical symptom that is prevalent among patients suffering from cerebral palsy. The treatment of spasticity with botulinum toxin type A (BTX-A) is a well-established option in the int...

Full description

Bibliographic Details
Main Authors: Ece Unlu, Alev Cevikol, Burcu Bal, Emel Gonen, Ozlem Celik, Gulşen Kose
Format: Article
Language:English
Published: Faculdade de Medicina / USP 2010-01-01
Series:Clinics
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322010000600009